Provider review, September 2026
Aspire says which of its legal entities you contract with depends on where you live and who is licensed to treat you. That is the most precise entity disclosure in this batch, on a site that publishes no price.
Aspire Health does not publish a price today.
Aspire Health also sells 1 compound this site boards without publishing a price for it: Sermorelin.
Aspire Health is not a paid partner; this link may earn a commission if that changes. Full disclosure.
The terms name a company doing business under the brand, then name an affiliated state-specific entity, and then publish the rule: services may be rendered through either, or through other affiliated entities, depending on provider licensure, patient location, operational considerations and applicable state or federal law.
Almost every telehealth seller in this market has a structure like that. Almost none writes it down, and fewer still tell a reader that the counterparty on their contract is determined by their own address.
It is a small paragraph that answers a question a reader could not otherwise answer at all.
The seller says certain medications offered through it, including certain peptide therapies, are not approved in their compounded form, and asks the reader to acknowledge three things: that compounded medications have not undergone the same review for safety, efficacy or manufacturing quality; that regulators and manufacturers may change the rules around availability; and that supply may be discontinued.
The third of those is a genuine consumer risk almost nobody discloses — that the product you start on may stop being available for reasons that have nothing to do with you.
It also says compounded medication is prepared by licensed compounding pharmacies on a provider's prescription for an individual patient, which is the correct description of the mechanism.
The page contains exactly one dollar amount, inside a limitation-of-liability clause. It is not a price and this row does not record one.
One compound this site tracks has a dedicated page. No dispensing pharmacy is named — a pharmacy-shaped phrase on the page turns out to be the name of a federal statute, not a facility.
No state coverage is published, which is a particular gap given that the seller's own entity rule turns on the reader's state. The footer copyright is a year out of date.
Auren Rx names both its prescribing group, Wasef Health, and its dispensing pharmacy, VialsRX in Houston, with street addresses and phone numbers, and lets a subscriber pause an auto-refill plan on NAD+, sermorelin, glutathione or GHK-Cu instead of forcing a full cancellation.
Auren Rx is not a paid partner; this link may earn a commission if that changes. Full disclosure.
Visit Auren RxIt depends on your state and on provider licensure. The terms name two entities and publish the rule that decides between them.
No. The only dollar amount on the page sits inside a limitation-of-liability clause.
That certain peptide therapies are not approved in their compounded form, that compounded products have not had the same review, and that supply may be discontinued if rules change.
No. A pharmacy-shaped phrase on the page is the name of a federal statute, not a facility.
None are published, which matters more here than usual because the entity rule turns on the reader's state.
Aspire Health is not a paid partner; this link may earn a commission if that changes. Full disclosure.